CDKN1A and neoplasm: With respect to the TP53 pathway, it is interesting to notice that we found high expression levels of the CDKN1A mRNA in the tumor samples of 11 patients (20%) and large amounts of the MDM2 (p53-binding protein) mRNA in a single patient (Figure 1).